Drugs / Lactobacillus casei rhamnosus

Trials 4 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 31 trial
Phase 3 NCT02979288 May 2017 → Nov 2020 bacterial infectious disease Medical University of Vienna Completed No outcome recorded
Phase 41 trial
Phase 4 NCT00437580 Feb 2007 → Aug 2009 Enterococcus faecalis infection University Hospital, Clermont-Ferrand Unknown No outcome recorded
Phase not applicable2 trials
NCT00166868 Dec 2003 → Jan 2012 biliary atresia National Taiwan University Hospital Completed No outcome recorded
NCT00621803 Mar 2003 → Oct 2004 Pseudomonas aeruginosa infectious disease University Hospital, Clermont-Ferrand Terminated No outcome recorded

Evidence & citations 8 cited values

Every value below carries the sentence it was read from. 5 sources stand behind the page.

FieldValueCited text
Known as Lactobacillus casei rhamnosus ClinicalTrials.gov intervention name — accepted as the source's own label NCT00437580
3

NCT00621803

NCT00166868

NCT02979288

Known as L. Casei rhamnosus LCR 35 “All pregnant women between 10 + 0 (10 weeks plus 0 days) and 16 + 0 (16 weeks plus 0 days) gestational weeks in study group will be treated with vaginal Lactobacilli Capsules...” NCT02979288
Known as Lcr 35 LC “Lactobacillus casei rhamnosus (strain Lcr 35 LC)” NCT00437580
Known as Lcr 35 regenerans “Lactobacillus casei rhamnosus (Lcr 35 regenerans)” NCT02979288
Known as Lcr regenerans “876,9 mg Lactobacillus casei rhamnosus (Lcr regenerans) in concentration of 107 CFU/ml” NCT02979288
Known as Lcr35 “Administration of Lactobacillus rhamnosus Lcr35 but not Escherichia coli Nissle reduced, although not significantly, the density of VRE colonization in a murine model.” PMID 20421444 Apr 2010
2

“Probiotic Lactobacillus casei rhamnosus (Lcr35)” NCT00621803

“Lactobacillus casei rhamnosus (Lcr35)” NCT00166868

Modality Other / unclassified “with the probiotic” NCT00437580
Route Oral “receive twice a day either an oral dose of Lactobacillus casei rhamnosus” NCT00621803